Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men
Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older
Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis
Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture
HORIZON-PFT: Pivotal Fracture Trial
† Study has passed its completion date and status has not been verified in more than two years.